MRNA · 10-Q · 2026Q3 · Full report
Seasonal Demand Trends
Moderna, Inc. · 2026-11-06 · Importance 20 · Surprise 6
Moderna anticipates seasonal fluctuations in demand for its COVID, influenza and RSV vaccines. Management expects higher sales during the fall and winter seasons. The filing does not quantify the anticipated seasonal impact.
Key facts
- Moderna anticipated higher sales of its COVID, influenza and RSV vaccines during fall and winter seasons. source